EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY 4.0

The role of Toll‐like receptors in neuropsychiatric disorders: Immunopathology, treatment, and management

Kiarash Saleki iD, Parsa Alijanizadeh, Nima Javanmehr, Nima Rezaei iD

Medicinal Research Reviews · 2024-05 · 44 (3) · 1267-1325

DOI: 10.1002/med.22012 ↗

At a glance

Übersichtsarbeit in Medicinal Research Reviews, published online on 2024-01-16. Written by Kiarash Saleki and 3 co-authors. Institution: Student Research Committee, Babol University of Medical Sciences, Babol, Iran. Major MEDLINE topics: Major Depressive Disorder. Cited 56 times so far (Crossref); 388 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Neuropsychiatric disorders denote a broad range of illnesses involving neurology and psychiatry. These disorders include depressive disorders, anxiety, schizophrenia, bipolar disorder, attention deficit hyperactivity disorder, autism spectrum disorders, headaches, and epilepsy. In addition to their main neuropathology that lies in the central nervous system (CNS), lately, studies have highlighted the role of immunity and neuroinflammation in neuropsychiatric disorders. Toll‐like receptors (TLRs) are innate receptors that act as a bridge between the innate and adaptive immune systems via adaptor proteins (e.g., MYD88) and downstream elements; TLRs are classified into 13 families that are involved in normal function and illnesses of the CNS. TLRs expression affects the course of neuropsychiatric disorders, and is influenced during their pharmacotherapy; For example, the expression of multiple TLRs is normalized during the major depressive disorder pharmacotherapy. Here, the role of TLRs in neuroimmunology, treatment, and management of neuropsychiatric disorders is discussed. We recommend longitudinal studies to comparatively assess the cell‐type‐specific expression of TLRs during treatment, illness progression, and remission. Also, further research should explore molecular insights into TLRs regulation and related pathways.

Subjects

MeSH terms (MEDLINE)

Major Depressive DisorderHumansToll-Like ReceptorsCentral Nervous SystemImmunity, Innate

Author keywords

Toll‐like receptorsinnate immunityneuroimmunologyneuropsychiatric disorderspattern recognition receptors

Substances

Toll-Like Receptors

Authors and institutions

  • Student Research Committee, Babol University of Medical Sciences, Babol, Iran.
  • USERN Office, Babol University of Medical Sciences, Babol, Iran.
  • Department of e-Learning, Virtual School of Medical Education and Management, Shahid Beheshti University of Medical Sciences (SBMU), Tehran, Iran.
  • Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.

ORCID profiles: Kiarash Saleki, Nima Rezaei

Cite

APA

Saleki, K., Alijanizadeh, P., Javanmehr, N., & Rezaei, N. (2024). The role of Toll‐like receptors in neuropsychiatric disorders: Immunopathology, treatment, and management. Medicinal Research Reviews, 44(3), 1267-1325. https://doi.org/10.1002/med.22012

Vancouver

Saleki K, Alijanizadeh P, Javanmehr N, Rezaei N. The role of Toll‐like receptors in neuropsychiatric disorders: Immunopathology, treatment, and management. Medicinal Research Reviews. 2024;44(3):1267-1325. doi:10.1002/med.22012

BibTeX
@article{Saleki2024,
  author = {Saleki, Kiarash and Alijanizadeh, Parsa and Javanmehr, Nima and Rezaei, Nima},
  title = {The role of Toll‐like receptors in neuropsychiatric disorders: Immunopathology, treatment, and management},
  journal = {Medicinal Research Reviews},
  year = {2024},
  volume = {44},
  number = {3},
  pages = {1267--1325},
  doi = {10.1002/med.22012}
}
Start for free →